⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AXGN News
Axogen, Inc. Common Stock
Nerve Repair and Regeneration Market worth $12.64 billion by 2031 - Exclusive Report by MarketsandMarkets™
prnewswire.com
BSX
AXGN
MDT
ABT
BIIB
GNRC
ECOR
Form 8-K/A
sec.gov
AXGN
Form 8-K
sec.gov
AXGN
Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock
globenewswire.com
AXGN
Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies
globenewswire.com
AXGN
Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference
globenewswire.com
AXGN
Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It
globenewswire.com
CNXU
VCEL
AXGN
KRYS
NVST
Form 8-K
sec.gov
AXGN
Trace Biosciences Announces Strategic Investment from Axogen to Advance Clinical Development of its Nerve Trace Nerve-Specific Imaging Technology
prnewswire.com
AXGN
Axogen, Inc. Reports Second Quarter 2026 Financial Results
globenewswire.com
AXGN